One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy

Alison E Hunter-Smith, Zenon Rayter Breast Surgery Unit, Bristol Breast Care Centre, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK Abstract: Breast cancer is the most common cancer in women, worldwide, and 1,400 deaths per day are attributed to it. The success o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hunter-Smith AE, Rayter Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/0fdda85fc8bf443bbd70cdf95b91956c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0fdda85fc8bf443bbd70cdf95b91956c
record_format dspace
spelling oai:doaj.org-article:0fdda85fc8bf443bbd70cdf95b91956c2021-12-02T06:01:06ZOne-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy1179-1314https://doaj.org/article/0fdda85fc8bf443bbd70cdf95b91956c2018-01-01T00:00:00Zhttps://www.dovepress.com/one-step-nucleic-acid-amplification-the-possible-value-in-assessing-se-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Alison E Hunter-Smith, Zenon Rayter Breast Surgery Unit, Bristol Breast Care Centre, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK Abstract: Breast cancer is the most common cancer in women, worldwide, and 1,400 deaths per day are attributed to it. The success of national screening programs has seen breast cancers being diagnosed at an earlier stage. With conservative surgery to the breast demonstrating equivalent long-term outcomes, the last 10 years have seen a growing interest in the safety of less invasive management for the axilla in breast cancer patients. One-step nucleic acid amplification (OSNA) is a validated, reliable, and efficient tool in identifying micro- and macro-metastases intraoperatively. It is the most widely used intraoperative analysis tool within the United Kingdom, and is employed by over 320 units across Europe and Asia. Recent evidence from the AMAROS, IBCSG 23-01, and ACOSOG Z0011 trials has changed surgical practice in managing the axilla of patients with breast cancer. We propose a clinical algorithm demonstrating the role of OSNA as an intraoperative analysis tool in today’s management of breast cancer as well as prospects for the future use of OSNA. Keywords: breast cancer, sentinel lymph node, intraoperative assessment, one-stop nucleic acid amplification, mastectomyHunter-Smith AERayter ZDove Medical Pressarticlebreast cancersentinel lymph nodeintra-operative assessmentone-stop nucleic acid amplification.Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 10, Pp 13-21 (2018)
institution DOAJ
collection DOAJ
language EN
topic breast cancer
sentinel lymph node
intra-operative assessment
one-stop nucleic acid amplification.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle breast cancer
sentinel lymph node
intra-operative assessment
one-stop nucleic acid amplification.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hunter-Smith AE
Rayter Z
One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
description Alison E Hunter-Smith, Zenon Rayter Breast Surgery Unit, Bristol Breast Care Centre, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK Abstract: Breast cancer is the most common cancer in women, worldwide, and 1,400 deaths per day are attributed to it. The success of national screening programs has seen breast cancers being diagnosed at an earlier stage. With conservative surgery to the breast demonstrating equivalent long-term outcomes, the last 10 years have seen a growing interest in the safety of less invasive management for the axilla in breast cancer patients. One-step nucleic acid amplification (OSNA) is a validated, reliable, and efficient tool in identifying micro- and macro-metastases intraoperatively. It is the most widely used intraoperative analysis tool within the United Kingdom, and is employed by over 320 units across Europe and Asia. Recent evidence from the AMAROS, IBCSG 23-01, and ACOSOG Z0011 trials has changed surgical practice in managing the axilla of patients with breast cancer. We propose a clinical algorithm demonstrating the role of OSNA as an intraoperative analysis tool in today’s management of breast cancer as well as prospects for the future use of OSNA. Keywords: breast cancer, sentinel lymph node, intraoperative assessment, one-stop nucleic acid amplification, mastectomy
format article
author Hunter-Smith AE
Rayter Z
author_facet Hunter-Smith AE
Rayter Z
author_sort Hunter-Smith AE
title One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
title_short One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
title_full One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
title_fullStr One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
title_full_unstemmed One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
title_sort one-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/0fdda85fc8bf443bbd70cdf95b91956c
work_keys_str_mv AT huntersmithae onestepnucleicacidamplificationthepossiblevalueinassessingsentinellymphnodemetastasisduringmastectomy
AT rayterz onestepnucleicacidamplificationthepossiblevalueinassessingsentinellymphnodemetastasisduringmastectomy
_version_ 1718400093270310912